Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" [Am Heart J 169/6 (2015) 890-898].
Publication
, Journal Article
Armstrong, PW; Zheng, Y; Westerhout, CM; Rosell-Ortiz, F; Sinnaeve, P; Lambert, Y; Lopes, RD; Bluhmki, E; Danays, T; Van de Werf, F ...
Published in: Am Heart J
February 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
February 2017
Volume
184
Start / End Page
157
Location
United States
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, P. W., Zheng, Y., Westerhout, C. M., Rosell-Ortiz, F., Sinnaeve, P., Lambert, Y., … STREAM investigators, . (2017). Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" [Am Heart J 169/6 (2015) 890-898]. Am Heart J, 184, 157. https://doi.org/10.1016/j.ahj.2017.01.005
Armstrong, Paul W., Yinggan Zheng, Cynthia M. Westerhout, Fernado Rosell-Ortiz, Peter Sinnaeve, Yves Lambert, Renato D. Lopes, et al. “Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" [Am Heart J 169/6 (2015) 890-898].” Am Heart J 184 (February 2017): 157. https://doi.org/10.1016/j.ahj.2017.01.005.
Armstrong PW, Zheng Y, Westerhout CM, Rosell-Ortiz F, Sinnaeve P, Lambert Y, et al. Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" [Am Heart J 169/6 (2015) 890-898]. Am Heart J. 2017 Feb;184:157.
Armstrong, Paul W., et al. “Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" [Am Heart J 169/6 (2015) 890-898].” Am Heart J, vol. 184, Feb. 2017, p. 157. Pubmed, doi:10.1016/j.ahj.2017.01.005.
Armstrong PW, Zheng Y, Westerhout CM, Rosell-Ortiz F, Sinnaeve P, Lambert Y, Lopes RD, Bluhmki E, Danays T, Van de Werf F, STREAM investigators. Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" [Am Heart J 169/6 (2015) 890-898]. Am Heart J. 2017 Feb;184:157.
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
February 2017
Volume
184
Start / End Page
157
Location
United States
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology